✦ LIBER ✦

Initiation of symptomatic therapy in Parkinson's disease: dopamine agonists versus levodopa

✍ Scribed by Nirit Lev; Ruth Djaldetti; Eldad Melamed

Publisher: Springer
Year: 2007
Tongue: English
Weight: 296 KB
Volume: 254
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-007-5004-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early dopamine agonist therapy in Parkin

Early dopamine agonist therapy in Parkinson's disease

✍ Prof. U. K. Rinne 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

Dopamine receptor agonists in the therap

Dopamine receptor agonists in the therapy of Parkinson’s disease

✍ P. Foley; M. Gerlach; K. L. Double; P. Riederer 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 424 KB

The effect of dopamine agonist therapy o

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

✍ J. Eric Ahlskog; Ryan J. Uitti; Michael K. O'Connor; Demetrius M. Maraganore; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Current Status of Symptomatic Medical Th

Current Status of Symptomatic Medical Therapy in Parkinson’s Disease

✍ Stewart A. Factor 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 153 KB

Symptomatic medical therapies for Parkinson's disease (PD) have been disease modifying and have led to improvement in daily function, quality of life, and survival. For 40 years, these therapies have been primarily dopaminergic, and currently include the dopamine (DA) precursor levodopa (LD), DA ago

Dopamine agonist-based strategies in the

Dopamine agonist-based strategies in the treatment of Parkinson’s disease

✍ Angelo Antonini; Paolo Barone 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 112 KB

Evidence-based initiation of dopaminergi

Evidence-based initiation of dopaminergic therapy in Parkinson's disease

✍ Janis M. Miyasaki 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 152 KB